suicide

Health Tech, Policy, Artificial Intelligence
Digital generated image of young woman wiht dark skin standing on grey ramp surrounded with multicoloured message chat icons trying to interact with them.

Faceless Advice, Real Consequences: The Challenge of AI Chatbots in Mental Health

As AI chatbots become a surrogate for human connection amid a national mental health crisis, experts are worried about these tools’ lack of safeguards — with research showing the models can provide dangerous, sometimes fatal, advice. Regulators and providers alike are scrambling to catch up with a technology that evolves faster than humans are able to understand.

presented by
presented by
presented by

Cerecor halfway through $32M Series B, developing “Special K”-like med for severe depression

Baltimore-based Cerecor has a fast-tracked, fast-acting drug called CER-301 that treats those with severe major depressive disorder and suicidal tendencies. And it works a little like ketamine, the anesthetic-turned-illicit party drug-turned-psychiatric therapy du jour. The company just raised a $16 million tranche in a $32 million Series B round to fund ongoing Phase 2 trials for the medication. It also plans to use […]